Correlation of HER2 gene and chromosome 17 status with pathologic factors in her2 2+ invasive breast cancer

被引：0
|
作者：
MacGrogan, G. [1 ]
Chibon, F. [1 ]
de Mascarel, I. [1 ]
Sierankowski, G. [1 ]
Brouste, V. [1 ]
机构：
[1] Inst Bergonie, Bordeaux, France
来源：
LABORATORY INVESTIGATION | 2007年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
162
引用
收藏
页码：40A / 40A
页数：1
相关论文
共 50 条
  • [21] Tumoral heterogeneity and HER2 status in invasive breast cancer
    Asselah, J.
    Cottu, P.
    Vincent-Salomon, A.
    Dieras, V
    Mignot, L.
    BULLETIN DU CANCER, 2007, 94 (06) : 568 - 568
  • [22] Reassessment of HER2 status in HER2 negative or HER2 unknown breast cancer patients with recurrent metastatic disease by analyzing serum HER2 and HER2 status of circulating tumor cells.
    Fehm, T.
    Lane, N.
    Solomayer, E.
    Wallwiener, D.
    Uhr, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S40
  • [23] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
    Bose, Ron
    Kavuri, Shyam M.
    Searleman, Adam C.
    Shen, Wei
    Shen, Dong
    Koboldt, Daniel C.
    Monsey, John
    Goel, Nicholas
    Aronson, Adam B.
    Li, Shunqiang
    Ma, Cynthia X.
    Ding, Li
    Mardis, Elaine R.
    Ellis, Matthew J.
    CANCER DISCOVERY, 2013, 3 (02) : 224 - 237
  • [24] HER2 0, HER2 1+and HER2 2+/FISH Negative Breast Cancers Are Biologically Different
    Mon, Khin Su
    Zhang, Hui
    Aragao, Alessa
    Tang, Ping
    LABORATORY INVESTIGATION, 2023, 103 (03) : S182 - S183
  • [25] Effect polysomy of chromosome 17 on the evaluation of HER2/neu status in breast cancer
    Lee, K.
    Hyun, C. L.
    Chung, J. H.
    Choi, G.
    Park, S. Y.
    MODERN PATHOLOGY, 2007, 20 : 40A - 40A
  • [26] Effect polysomy of chromosome 17 on the evaluation of HER2/neu status in breast cancer
    Lee, K.
    Hyun, C. L.
    Chung, J. H.
    Choi, G.
    Park, S. Y.
    LABORATORY INVESTIGATION, 2007, 87 : 40A - 40A
  • [27] Reassessment of HER2 status in breast cancer patients with initially HER2 negative or HER2 unknown primary tumors at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, T.
    Solomayer, E.
    Uhr, J.
    Wallwiener, D.
    ONKOLOGIE, 2008, 31 : 51 - 51
  • [28] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [29] HER2 status in bilateral breast cancer
    Crowe, Joseph P.
    Patrick, Rebecca J.
    Rybicki, Lisa A.
    Budd, G. Thomas
    Escobar, Pedro F.
    Tubbs, Raymond R.
    Hicks, David G.
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2006, 51 (05) : 219 - 223
  • [30] Assessment of HER2 status in breast cancer
    Penault-Llorca, F
    Cayre, A
    BULLETIN DU CANCER, 2004, 91 : S211 - S215
12345